103 related articles for article (PubMed ID: 8502696)
1. Prognostic significance of IgM anti-HD during interferon therapy.
Marinucci G; Hassan G; Di Giacomo C; Dato A; Barlattani A; Costa F
Prog Clin Biol Res; 1993; 382():311-8. PubMed ID: 8502696
[No Abstract] [Full Text] [Related]
2. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
Mederacke I; Yurdaydin C; Dalekos GN; Bremer B; Erhardt A; Cakaloglu Y; Yalcin K; Gurel S; Zeuzem S; Zachou K; Bozkaya H; Dienes HP; Manns MP; Wedemeyer H;
Antivir Ther; 2012; 17(2):305-12. PubMed ID: 22293066
[TBL] [Abstract][Full Text] [Related]
3. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation.
Borghesio E; Rosina F; Smedile A; Lagget M; Niro MG; Marinucci G; Rizzetto M
Hepatology; 1998 Mar; 27(3):873-6. PubMed ID: 9500721
[TBL] [Abstract][Full Text] [Related]
4. [Delta hepatitis].
Matsuda S; Okita K
Ryoikibetsu Shokogun Shirizu; 1995; (7):127-30. PubMed ID: 8749435
[No Abstract] [Full Text] [Related]
5. Alpha interferon therapy of chronic delta hepatitis: a pilot study.
Di Bisceglie AM; Negro F; Smedile A; Bergmann K; Hoofnagle JH
Prog Clin Biol Res; 1991; 364():393-7. PubMed ID: 2020714
[No Abstract] [Full Text] [Related]
6. Long term interferon treatment of chronic delta hepatitis: a multicenter Italian study.
Rosina F; Pintus C; Meschievitz C; Rizzetto M
Prog Clin Biol Res; 1991; 364():385-91. PubMed ID: 2020713
[No Abstract] [Full Text] [Related]
7. [Short communication: evaluation of the correlation between hepatitis D virus (HDV) RNA positivity and HDV antibodies].
Ozekinci T; Atmaca S; Akpolat N; Temiz H; Arikan E
Mikrobiyol Bul; 2005 Jul; 39(3):345-9. PubMed ID: 16358495
[TBL] [Abstract][Full Text] [Related]
8. Therapy of chronic delta hepatitis with alpha- and beta-interferon.
Gaudin JL; Trépo C
Prog Clin Biol Res; 1993; 382():345-52. PubMed ID: 8502701
[No Abstract] [Full Text] [Related]
9. [Combined therapy with recombinant alfa-2 and gamma interferons in patients with chronic hepatitis delta virus infection].
Fedorchenko SV
Klin Med (Mosk); 1996; 74(2):35-7. PubMed ID: 8772100
[TBL] [Abstract][Full Text] [Related]
10. IgM anti-HD in acute hepatitis D: diagnostic and prognostic significance.
Aragona M; Macagno S; Caredda F; Crivelli O; Lavarini C; Bertolusso L; Farci P; Rizzetto M
Prog Clin Biol Res; 1987; 234():243-8. PubMed ID: 3628379
[No Abstract] [Full Text] [Related]
11. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
[No Abstract] [Full Text] [Related]
12. Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology.
Kleiner D; Di Bisceglie AM; Axiotis CA; Hoofnagle JH
Prog Clin Biol Res; 1993; 382():365-71. PubMed ID: 8502705
[TBL] [Abstract][Full Text] [Related]
13. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
[No Abstract] [Full Text] [Related]
14. Chronic delta hepatitis: detection of hepatitis delta virus antigen in serum by immunoblot and correlation with other markers of delta viral replication.
Buti M; Esteban R; Jardi R; Rodriguez-Frias F; Casacuberta J; Esteban JI; Allende E; Guardia J
Hepatology; 1989 Dec; 10(6):907-10. PubMed ID: 2583685
[TBL] [Abstract][Full Text] [Related]
15. Acute delta hepatitis: serological diagnosis with particular reference to hepatitis delta virus RNA.
Gupta S; Govindarajan S; Cassidy WM; Valinluck B; Redeker AG
Am J Gastroenterol; 1991 Sep; 86(9):1227-31. PubMed ID: 1882801
[TBL] [Abstract][Full Text] [Related]
16. [Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 4: Hepatitis D serology].
Eisenburg J
Fortschr Med; 1995 Jan; 113(3):35-6. PubMed ID: 7890271
[No Abstract] [Full Text] [Related]
17. Spontaneous exacerbation of disease activity in patients with chronic delta hepatitis infection: the role of hepatitis B, C or D?
Ackerman Z; Valinluck B; McHutchison JG; Redeker AG; Govindarajan S
Hepatology; 1992 Sep; 16(3):625-9. PubMed ID: 1380478
[TBL] [Abstract][Full Text] [Related]
18. Delta viral replication markers in acute and chronic D infection.
Buti M
Prog Clin Biol Res; 1991; 364():201-5. PubMed ID: 2020696
[No Abstract] [Full Text] [Related]
19. Long term treatment of chronic delta hepatitis with alpha recombinant interferon.
Marinucci G; Hassan G; Di Giacomo C; Barlattani A; Costa F; Rasshofer R; Roggendorf M
Prog Clin Biol Res; 1991; 364():405-10. PubMed ID: 2020716
[No Abstract] [Full Text] [Related]
20. Italian trials of interferon alpha in chronic delta hepatitis.
Rosina F; Saracco G; Cozzolongo R; Costa C; Bonino F; Verme G; Rizzetto M
Prog Clin Biol Res; 1993; 382():353-8. PubMed ID: 8502703
[No Abstract] [Full Text] [Related]
[Next] [New Search]
